Abstract
Purpose
To assess the diagnostic performance of 18F-DOPA PET/CT and fused 18F-DOPA PET/MRI in detecting striatal involvement in children with gliomas.
Methods
This retrospective study included 28 paediatric patients referred to our institution for the presence of primary, residual or recurrent glioma (12 boys, 16 girls; mean age 10.7 years) and investigated with 18F-DOPA PET/CT and brain MRI. Fused 18F-DOPA PET/MR images were obtained and compared with PET/CT and MRI images. Accuracy, sensitivity, specificity, negative predictive value (NPV) and positive predictive value (PPV) for striatal involvement were calculated for each diagnostic tool. Univariate and multivariate logistic analyses were applied to evaluate the associations between 18F-DOPA PET/CT and fused 18F-DOPA PET/MRI diagnostic results and tumour uptake outside the striatum, grade, dimension and site of striatal involvement (ventral and/or dorsal).
Results
Accuracy, sensitivity, specificity, PPV, and NPV were 100 % for MRI, 93 %, 89 %, 100 %, 100 % and 82 % for 18F-DOPA PET/MRI, and 75 %, 74 %, 78 %, 88 % and 58 % for 18F-DOPA PET/CT, respectively. 18F-DOPA PET/MRI showed a trend towards higher accuracy compared with 18F-DOPA PET/CT (p = 0.06). MRI showed significantly higher accuracy compared with 18F-DOPA PET/CT (p = 0.01), but there was no significant difference between MRI and 18F-DOPA PET/MRI. Both univariate and multivariate logistic analyses showed a significant association (OR 8.0 and 7.7, respectively) between the tumour-to-normal striatal uptake (T/S) ratio and the diagnostic ability of 18F-DOPA PET/CT (p = 0.03). A strong significant association was also found between involvement of the dorsal striatum and the 18F-DOPA PET/CT results (p = 0.001), with a perfect prediction of involvement of the dorsal striatum by 18F-DOPA PET/MRI.
Conclusion
Physiological striatal 18F-DOPA uptake does not appear to be a main limitation in the evaluation of basal ganglia involvement.18F-DOPA PET/CT correctly detected involvement of the dorsal striatum in lesions with a T/S ratio >1, but appeared to be less suitable for evaluation of the ventral striatum. The use of fused 18F-DOPA PET/MRI further improves the accuracy and is essential for evaluation of the ventral striatum.
Similar content being viewed by others
References
Kaplan AM, Bandy DJ, Manwaring KH, Chen K, Lawson MA, Moss SD, et al. Functional brain mapping using positron emission tomography scanning in preoperative neurosurgical planning for pediatric brain tumors. J Neurosurg. 1999;91:797–803.
Pirotte B, Goldman S, Salzberg S, Wikler D, David P, Vandesteene A, et al. Combined positron emission tomography and magnetic resonance imaging for the planning of stereotactic brain biopsies in children: experience in 9 cases. Pediatr Neurosurg. 2003;38:146–55.
Morana G, Piccardo A, Milanaccio C, Puntoni M, Nozza P, Cama A, et al. Value of 18F-3,4-dihydroxyphenylalanine PET/MR image fusion in pediatric supratentorial infiltrative astrocytomas: a prospective pilot study. J Nucl Med. 2014;55:718–23.
Morana G, Piccardo A, Garrè ML, Nozza P, Consales A, Rossi A. Multimodal magnetic resonance imaging and 18F-L-dihydroxyphenylalanine positron emission tomography in early characterization of pseudoresponse and nonenhancing tumor progression in a pediatric patient with malignant transformation of ganglioglioma treated with bevacizumab. J Clin Oncol. 2013;31:e1–5.
Piccardo A, Lopci E, Conte M, Garaventa A, Foppiani L, Altrinetti V, et al. Comparison of 18F-DOPA PET/CT and 123IMIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study. Eur J Nucl Med Mol Imaging. 2012;39:57–71.
Piccardo A, Puntoni M, Lopci E, Conte M, Foppiani L, Sorrentino S, et al. Prognostic value of 18F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma. Eur J Nucl Med Mol Imaging. 2014;41:1046–56.
Piccardo A, Morana G, Massollo M, Pescetto M, Conte M, Garaventa A. Brain metastasis from neuroblastoma depicted by 18F-DOPA PET/CT. Nucl Med Mol Imaging. 2015;49:241–2. doi:10.1007/s13139-015-0322-8.
Ribeiro MJ, De Lonlay P, Delzescaux T, Boddaert N, Jaubert F, Bourgeois S, et al. Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA. J Nucl Med. 2005;46:560–6.
Morana G, Piccardo A, Puntoni M, Nozza P, Cama A, Raso A, et al. Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study. Neuro Oncol. 2015;17:1637–47.
Misch M, Guggemos A, Driever PH, Koch A, Grosse F, Steffen IG, et al. (18)F-FET-PET guided surgical biopsy and resection in children and adolescence with brain tumors. Childs Nerv Syst. 2015;31:261–7.
Dunkl V, Cleff C, Stoffels G, Judov N, Sarikaya-Seiwert S, Law I, et al. The usefulness of dynamic O-(2-18F-fluoroethyl)-L-tyrosine PET in the clinical evaluation of brain tumors in children and adolescents. J Nucl Med. 2015;56:88–92.
Fraioli F, Shankar A, Hargrave D, Hyare H, Gaze MN, Groves AM, et al. 18F-fluoroethylcholine (18F-Cho) PET/MRI functional parameters in pediatric astrocytic brain tumors. Clin Nucl Med. 2015;40:e40–5.
Porter JN, Roy AK, Benson B, Carlisi C, Collins PF, Leibenluft E, et al. Age-related changes in the intrinsic functional connectivity of the human ventral vs. dorsal striatum from childhood to middle age. Dev Cogn Neurosci. 2015;11:83–95.
Galldiks N, Langen KJ, Pope WB. From the clinician’s point of view – What is the status quo of positron emission tomography in patients with brain tumors? Neuro Oncol. 2015;17:1434–44.
Lapa C, Linsenmann T, Monoranu CM, Samnick S, Buck AK, Bluemel C, et al. Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients. J Nucl Med. 2014;55:1611–6.
Kratochwil C, Combs SE, Leotta K, Afshar-Oromieh A, Rieken S, Debus J, et al. Intra-individual comparison of 18F-FET and 18F-DOPA in PET imaging of recurrent brain tumors. Neuro Oncol. 2014;16:434–40.
Morana G, Piccardo A, Garrè ML, Nobili F, Rossi A. Late persistent increased putaminal 18F-DOPA uptake following ipsilateral frontal resection: evidence for corticostriatal synaptic plasticity? Clin Nucl Med. 2015;40:e451–2.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None.
Ethical approval
For this type of study (retrospective study) formal consent is not required. This article does not describe any studies with animals performed by any of the authors.
Informed consent
Informed consent was signed by all patients or their legal guardians, and patient assent was obtained whenever appropriate.
Rights and permissions
About this article
Cite this article
Morana, G., Puntoni, M., Garrè, M.L. et al. Ability of 18F-DOPA PET/CT and fused 18F-DOPA PET/MRI to assess striatal involvement in paediatric glioma. Eur J Nucl Med Mol Imaging 43, 1664–1672 (2016). https://doi.org/10.1007/s00259-016-3333-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-016-3333-5